// App-Quantinova.ai

2717 : Long-term Outcome of Juvenile-onset Psoriatic Arthritis

Researchers

Presenter

  • Tal Gazitt

Principal Investigators

  • Amir Haddad

  • Idit Lavi

  • Snezana Barac

  • Vinod Chandran

  • Jan Dutz

  • Lihi Eder

  • James T Elder

  • Richard Hayday

  • Proton Rahman

  • Christopher Ritchlin

  • Sherry Rohekar

  • Cheryl F. Rosen

  • Dafna Gladman

Medical Centers

  • Carmel Hospital and Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel, Haifa, Israel

  • Carmel Hospital, Haifa, Israel

  • Winnipeg Clinic, Winnipeg, MB, Canada

  • Department of Medicine, University of Toronto,Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada

  • University of Michigan Medical School, Ann Arbor, MI

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Memorial University, Newfoundland, Canada

  • Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY

  • Western Univeristy, London, ON, Canada

  • Rheumatology, U of Toronto, Toronto Western Hospital, Toronto, ON, Canada

  • Toronto Western Hospital, Toronto, Canada, Toronto, ON, Canada

Locations

  • Israel

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Psoriatic arthritis

  • Dactylitis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A